Globe Life (GL) Expected to Announce Quarterly Earnings on Wednesday

Globe Life (NYSE:GLGet Free Report) is projected to announce its Q2 2026 results after the market closes on Wednesday, July 22nd. Analysts expect Globe Life to post earnings of $3.67 per share and revenue of $1.5904 billion for the quarter. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Individuals may review the information on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, July 23, 2026 at 11:00 AM ET.

Globe Life (NYSE:GLGet Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The company had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the prior year, the business posted $3.07 EPS. The company’s revenue was up 5.3% on a year-over-year basis. On average, analysts expect Globe Life to post $16 EPS for the current fiscal year and $17 EPS for the next fiscal year.

Globe Life Trading Up 0.1%

GL stock opened at $184.93 on Monday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life has a twelve month low of $120.05 and a twelve month high of $191.55. The stock has a market capitalization of $14.36 billion, a price-to-earnings ratio of 12.79 and a beta of 0.47. The firm’s fifty day simple moving average is $166.55 and its two-hundred day simple moving average is $151.61.

Globe Life Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.7%. The ex-dividend date is Monday, July 6th. Globe Life’s dividend payout ratio is presently 9.13%.

Insider Buying and Selling at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 10,000 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $166.68, for a total value of $1,666,800.00. Following the completion of the sale, the chief executive officer directly owned 54,020 shares in the company, valued at approximately $9,004,053.60. This represents a 15.62% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 7,936 shares of the firm’s stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $156.59, for a total value of $1,242,698.24. Following the transaction, the chief financial officer owned 50,496 shares in the company, valued at approximately $7,907,168.64. This represents a 13.58% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 124,187 shares of company stock worth $19,529,414 over the last quarter. Insiders own 2.11% of the company’s stock.

Institutional Investors Weigh In On Globe Life

Several large investors have recently modified their holdings of GL. Compound Planning Inc. raised its position in Globe Life by 4.3% during the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after acquiring an additional 82 shares during the last quarter. Parallel Advisors LLC grew its holdings in Globe Life by 5.6% during the 4th quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after buying an additional 87 shares during the last quarter. Laird Norton Wetherby Wealth Management LLC raised its holdings in shares of Globe Life by 2.2% in the third quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock worth $646,000 after acquiring an additional 99 shares during the last quarter. Cetera Investment Advisers lifted its position in shares of Globe Life by 1.3% in the fourth quarter. Cetera Investment Advisers now owns 8,861 shares of the company’s stock valued at $1,239,000 after acquiring an additional 113 shares in the last quarter. Finally, Transamerica Financial Advisors LLC lifted its position in shares of Globe Life by 46.0% in the fourth quarter. Transamerica Financial Advisors LLC now owns 543 shares of the company’s stock valued at $76,000 after acquiring an additional 171 shares in the last quarter. Institutional investors own 81.61% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Truist Financial raised their price objective on shares of Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Friday, April 24th. Keefe, Bruyette & Woods boosted their price objective on Globe Life from $180.00 to $192.00 and gave the company an “outperform” rating in a report on Monday, July 13th. Jefferies Financial Group upped their price objective on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research report on Friday, July 10th. TD Cowen lifted their target price on Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a research report on Tuesday, June 23rd. Finally, Wells Fargo & Company upped their price target on shares of Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a report on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $184.60.

View Our Latest Report on Globe Life

About Globe Life

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Featured Articles

Earnings History for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.